Chaitan S. Khosla
Director/Board Member presso FIRST WAVE BIOPHARMA, INC.
Patrimonio netto: 3 472 $ in data 29/02/2024
Profilo
Founder of Kosan Biosciences, Inc., Celiac Sprue Research Foundation Corp., Sitari Pharma, Inc. and Alvine Pharmaceuticals, Inc., Chaitan S.
Khosla is an entrepreneur is on the board of Protagonist Pty Ltd.
and First Wave Biopharma, Inc. and Professor at Stanford University, Member of American Academy of Arts & Sciences, Member of National Academy of Engineering and Founding Director at Stanford Chem-H.
In the past Dr. Khosla held the position of President of Celiac Sprue Research Foundation Corp., Director at Alvine Pharmaceuticals, Inc. and Director at Kosan Biosciences, Inc.
He received an undergraduate degree from Indian Institute of Technology Bombay and a doctorate from California Institute of Technology.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
13/03/2024 | 440 ( 0.07% ) | 3 472 $ | 29/02/2024 |
Posizioni attive di Chaitan S. Khosla
Società | Posizione | Inizio |
---|---|---|
FIRST WAVE BIOPHARMA, INC. | Director/Board Member | 13/03/2024 |
Stanford University | Corporate Officer/Principal | 01/01/2001 |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Corporate Officer/Principal | - |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The private company is based in Washington. | Corporate Officer/Principal | - |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Director/Board Member | - |
Stanford Chem-H | Corporate Officer/Principal | 01/01/2013 |
Precedenti posizioni note di Chaitan S. Khosla
Società | Posizione | Fine |
---|---|---|
ImmunogenX LLC
ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Director/Board Member | 13/03/2024 |
PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 11/08/2020 |
Alvine Pharmaceuticals, Inc.
Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Alvine Pharmaceuticals, Inc. develops and commercializes therapeutics for inflammatory diseases. It offers ALV003, tTG Inihibitors and HLA-DQ2 Blockers. The company was founded by Blair Stewart and Kevin R. Kaster in 2005 and is headquartered in San Carlos, CA. | Founder | 01/01/2016 |
░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░ | - |
Formazione di Chaitan S. Khosla
California Institute of Technology | Doctorate Degree |
Indian Institute of Technology Bombay | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PROTAGONIST THERAPEUTICS, INC. | Health Technology |
Aziende private | 10 |
---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Alvine Pharmaceuticals, Inc.
Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Alvine Pharmaceuticals, Inc. develops and commercializes therapeutics for inflammatory diseases. It offers ALV003, tTG Inihibitors and HLA-DQ2 Blockers. The company was founded by Blair Stewart and Kevin R. Kaster in 2005 and is headquartered in San Carlos, CA. | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Health Technology |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Commercial Services |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The private company is based in Washington. | Commercial Services |
Celiac Sprue Research Foundation Corp. | |
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Health Technology |
First Wave Biopharma, Inc. | |
ImmunogenX LLC
ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Health Technology |
Stanford Chem-H |